Lv1
33 积分 2020-09-27 加入
Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy—results from preclinical in-silico dose comparison and quality assurance
3个月前
已关闭
Survival outcomes and safety of nimotuzumab combined with radiotherapy ± chemotherapy for locally advanced cervical cancer
4个月前
已完结
A phase I clinical trial of radiation therapy, durvalumab and tremelimumab in recurrent gynecologic cancer
4个月前
已完结
Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses
4个月前
已完结
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study
4个月前
已完结
Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer
4个月前
已完结
Locoregional Treatment in Patients With Metastatic Cervical Cancer: Benefit of Dose Escalation Strategies
4个月前
已完结
Cancer control and toxicity results of chemoradiation for cervical cancer using a three-fraction HDR brachytherapy boost
11个月前
已关闭
Patient-Reported Outcome Measures in Clinical Research
1年前
已完结
Patient-Reported Outcome Measures in Clinical Research
1年前
已完结
皖公网安备34019202002308
